Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

NCT00002816 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents

NCT03020030 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia

NCT00313053 ·Status: TERMINATED ·Phase: PHASE1

Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

NCT00381680 ·Status: COMPLETED ·Phase: PHASE3

Raltitrexed in Treating Children With Refractory Acute Leukemia

NCT00003528 ·Status: COMPLETED ·Phase: PHASE1

Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia

NCT00003729 ·Status: TERMINATED ·Phase: PHASE2

Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma

NCT00317408 ·Status: UNKNOWN ·Phase: NA

A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL

NCT01483690 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00186875 ·Status: COMPLETED ·Phase: PHASE2

Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia

NCT00411541 ·Status: COMPLETED ·Phase: PHASE4

Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

NCT00006462 ·Status: COMPLETED ·Phase: PHASE2

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

NCT03117751 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Osteonecroses in Pediatric Patients With ALL

NCT01619124 ·Status: UNKNOWN

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

NCT06620302 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia

NCT00003933 ·Status: COMPLETED ·Phase: NA

Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT02303821 ·Status: COMPLETED ·Phase: PHASE1

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00557193 ·Status: COMPLETED ·Phase: PHASE3

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

NCT00002704 ·Status: COMPLETED ·Phase: PHASE2

Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse

NCT06649253 ·Status: RECRUITING ·Phase: NA

Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

NCT00003728 ·Status: UNKNOWN ·Phase: PHASE3

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

NCT00057811 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Childhood Acute Lymphoblastic Leukemia

NCT00165087 ·Status: TERMINATED ·Phase: PHASE3

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

NCT01614197 ·Status: COMPLETED ·Phase: PHASE1

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

NCT00083070 ·Status: COMPLETED ·Phase: PHASE1

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1